Safi R. Bahcall

2006

In 2006, Safi R. Bahcall earned a total compensation of $1.1M as President and Chief Executive Officer at Synta Pharmaceuticals.

Compensation breakdown

Bonus$100,000
Option Awards$265,518
Salary$340,000
Stock Awards$343,256
Other$38,610
Total$1,087,384

Bahcall received $343.3K in stock awards, accounting for 32% of the total pay in 2006.

Bahcall also received $100K in bonus, $265.5K in option awards, $340K in salary and $38.6K in other compensation.

Rankings

In 2006, Safi R. Bahcall's compensation ranked 2,899th out of 7,022 executives tracked by ExecPay. In other words, Bahcall earned more than 58.7% of executives.

ClassificationRankingPercentile
All
2,899
out of 7,022
59th
Division
Manufacturing
908
out of 2,413
62nd
Major group
Chemicals And Allied Products
194
out of 673
71st
Industry group
Drugs
118
out of 518
77th
Industry
Pharmaceutical Preparations
96
out of 355
73rd
Source: SEC filing on April 30, 2009.

Bahcall's colleagues

We found four more compensation records of executives who worked with Safi R. Bahcall at Synta Pharmaceuticals in 2006.

2006

Keizo Koya

Synta Pharmaceuticals

Senior Vice President, Drug Development

2006

James Barsoum

Synta Pharmaceuticals

Senior Vice President, Research

2006

Eric Jacobson

Synta Pharmaceuticals

Chief Medical Officer

2006

Keith Ehrlich

Synta Pharmaceuticals

Chief Financial Officer

You may also like